Radcliffe Capital Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-300,000
Closed -$2.96M 996
2021
Q1
$2.96M Buy
+300,000
New +$2.96M 0.12% 330